MINERALYS THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-22.9M | $10.7M |
| FY2022 | — | $-52.3M | $87.7M |
| FY2023 | — | $241.2M | $49.3M |
| FY2024 | — | $191.3M | $114.1M |
| FY2025 | — | $646.7M | $172.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-22.9M | $10.7M |
| FY2022 | — | $-52.3M | $87.7M |
| FY2023 | — | $241.2M | $49.3M |
| FY2024 | — | $191.3M | $114.1M |
| FY2025 | — | $646.7M | $172.9M |